Risultati di ricerca
4 giorni fa · IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin ...
4 giorni fa · Edwards Lifesciences on Monday said it has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business.
4 giorni fa · Key Takeaways. Medical device maker Becton Dickinson (BD) is buying the Critical Care product division of Edwards Lifesciences for $4.2 billion in cash. BD said the purchase will expand its ...
4 giorni fa · Ropes & Gray represented Becton, Dickinson and Company, BD, in a definitive agreement to acquire Edwards Lifesciences' Critical Care product group, a leader in advanced hemodynamic monitoring solutions, for $4.2 billion in cash.
4 giorni fa · Becton Dickinson BDX 2.96% agreed to acquire an Edwards Lifesciences EW 1.12% unit for $4.2 billion, in one of the company’s largest of many transactions. The medical technology company has...
4 giorni fa · BD to Acquire Edwards Lifesciences' Critical Care. Jun 3, 2024. Press Release. HTML. Presentation. PDF. By reading this content you are acknowledging our forward looking statement. Email Alerts.
4 giorni fa · B ecton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.
